Big Database

The company also pointed out the risks. Since the equity acquisition is a merger of companies under different control, after the completion of this transaction, the target company will become a wholly-owned subsidiary of the company, and a certain amount of goodwill is expected to be generated in the company's consolidated balance sheet. After this transaction, the company will fully integrate with the target company to ensure the target company's market competitiveness and long-term stable development capabilities. However, if there are adverse changes in the target company's future operating activities, the goodwill will be at risk of impairment and will have an adverse impact on the company's future current profit and loss.

Dai Lizhong, Chairman of Shengxiang Bio, said that efficient cyprus telegram data integration and personalization of prevention, diagnosis and treatment is the inevitable trend of proactive health, and is also the direction of Shengxiang Bio's innovation and exploration in the new era of life science.

The strong alliance between Shengxiang Bio and Zhongshan Haiji will leverage the resource advantages of precision diagnosis and biomanufacturing, which will help create an integrated health solution for pediatric diagnosis and treatment.


Before this merger and acquisition , Shengxiang Bio 's attributable net profit had declined for three consecutive years from 2021 to 2023 .